Bionomics Ev To Free Cash Flow from 2010 to 2024

BNOX Stock  USD 0.30  0.02  7.14%   
Bionomics EV To Free Cash Flow yearly trend continues to be fairly stable with very little volatility. EV To Free Cash Flow is likely to outpace its year average in 2024. EV To Free Cash Flow is a valuation metric comparing Bionomics' enterprise value to its free cash flow, used to evaluate whether Bionomics Ltd ADR is undervalued or overvalued. View All Fundamentals
 
EV To Free Cash Flow  
First Reported
2010-12-31
Previous Quarter
0.37086229
Current Value
0.39
Quarterly Volatility
K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Ev To Free Cash Flow Growth Pattern

Below is the plot of the Ev To Free Cash Flow of Bionomics Ltd ADR over the last few years. It is a valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued. Bionomics' EV To Free Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
Ev To Free Cash Flow10 Years Trend
Very volatile
   Ev To Free Cash Flow   
       Timeline  

Bionomics Ev To Free Cash Flow Regression Statistics

Arithmetic Mean(784.03)
Coefficient Of Variation(129.81)
Mean Deviation756.57
Median(321.33)
Standard Deviation1,018
Sample Variance1M
Range3K
R-Value(0.07)
Mean Square Error1.1M
R-Squared0.01
Significance0.80
Slope(16.69)
Total Sum of Squares14.5M

Bionomics Ev To Free Cash Flow History

2024 0.39
2023 0.37
2022 -226.45
2021 -628.2
2020 -2028.1
2019 -2975.37
2018 -697.74

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Ev To Free Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Free Cash Flow 0.37  0.39 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.